Status:
COMPLETED
A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients
Lead Sponsor:
Massachusetts General Hospital
Conditions:
MRSA Colonization
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Methicillin-resistant Staphylococcus aureus (MRSA) is endemic in hospital settings. Colonization with MRSA puts patients at increased risk for invasive infections, and MRSA infections have been associ...
Detailed Description
Compared with patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia, patients with MRSA bacteremia remained in the hospital for two more days on average and had a median attrib...
Eligibility Criteria
Inclusion
- age \> 18
- last positive MRSA culture greater than 3 months old
- admitted to hospital
Exclusion
- age \< 18
- last positive MRSA culture less than or equal to 3 months old
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
463 Patients enrolled
Trial Details
Trial ID
NCT01234831
Start Date
December 1 2010
End Date
March 1 2016
Last Update
October 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114